Cybin (CYBN)

Stock, pipeline and biotech catalyst intelligence

$8.28Price unavailableCached market snapshot

Market cap$413.1M

Cash$195.1M

Quarterly burn$31.9M

Pipeline assets2

Short float6.3%

Latest coverage

News & Press Releases

External sources

Aug 22, 2026

Cybin (CYBN) Stock Sees Fair Value Lift As Sector Research Supports Growth AssumptionsSimply Wall St.

Jul 25, 2026

Cybin (CYBN) Stock Fair Value Moves Lower As Analysts Rework Psychedelic Sector AssumptionsSimply Wall St.

Company profile

Cybin is a biotechnology company in the healthcare sector.

Company profile compiled from available company records. Catalyst dates can change and should be confirmed against the linked primary source.

Page updated Aug 23, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.